IGM #澳洲幸运5开奖结果历史查询 #2024澳洲幸运5官网直播 #澳洲5历史开奖记录官方正规网 and Sanofi collaboration will pivot to immunology and inflammation
The deal will now see IGM doubling down on IgM antibody development for immunology and inflammation targets.
The deal will now see IGM doubling down on IgM antibody development for immunology and inflammation targets.
The two companies will address the challenges of creating scalable and compliant AI medical imaging software products.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Q&A: BARDA wants to back tech that can combat multiple infections, says director
Can pharma overcome generative AI’s bias problem?
NVIDIA doubles down on AI in healthcare with drug discovery deals
Microsoft and NVIDIA expand collaboration in healthcare innovation